Warning of albumin shortages

Clinicians have been warned human albumin stocks could run low, after the product was quarantined nationwide amid contamination fears.

CSL Biotherapies, Australia's only supplier of the product, notified the Therapeutic Goods Administration on Wednesday that some of its batches of human albumin solutions were contaminated with ethylene glycol after a manufacturing equipment failure.

The TGA said all albumin products held by hospitals, the Australian Red Cross Blood

Latest

Trending